Skip to main content
. 2017 Dec 11;6:44. doi: 10.1186/s40169-017-0175-0

Fig. 1.

Fig. 1

Overview of established nanomedicines in the clinic. This diagram shows an overview of the nanomedicines currently being investigated in the clinic for cancer treatment. Lipid-based, polymer-based, inorganic, viral, and drug-conjugated nanoparticles are examples of platforms that have been established in clinical research

(Reproduced with permission from [3])